Treatment of herpes genitalis.
D000287:Administration, Topical; D000818:Animals; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use; D004121:Dimethyl Sulfoxide / Q000627:therapeutic use; D005260:Female; D006558:Herpes Genitalis / Q000188:drug therapy*; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D008297:Male; D011206:Povidone-Iodine / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use
D000891:Anti-Infective Agents, Local; D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D003561:Cytarabine; D011206:Povidone-Iodine; D014740:Vidarabine; D007065:Idoxuridine; D004121:Dimethyl Sulfoxide